Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|
1 | 2 | |||
Anaphylactic shock | postmarketing | x | ||
Angioedema | postmarketing | x | ||
Asthma | postmarketing | x | ||
Hypersensitivity | postmarketing | x | ||
Pruritus | postmarketing | x | x | |
Shock | postmarketing | x | ||
Urticaria | postmarketing | x | ||
Respiratory distress | postmarketing | x | ||
Localised oedema | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||
---|---|---|---|---|
Ascites chylous | x | x | ||
Chylothorax | x | x | ||
Chyluria | x | x | ||
Lymphoedema | x | x | ||
Metastatic neoplasm | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |